VolitionRX (VNRX, Financial), a company making strides in the field of cancer diagnostics, has caught the attention of Jones Trading. As of June 10, 2025, the prominent financial analyst firm has initiated coverage on the stock with a 'Buy' rating.
Justin Walsh, an analyst with Jones Trading, has set a price target for VolitionRX (VNRX, Financial) at $3.00 USD. This target reflects a positive outlook on the stock, although specific percentage changes or adjustments from prior targets were not provided in the report.
This latest action from Jones Trading marks the first time they have rated VolitionRX (VNRX, Financial), with no prior ratings or price targets available for comparison. Investors may find this new coverage a noteworthy development as the analyst firm is known for its comprehensive market insights.
As VolitionRX (VNRX, Financial) continues its efforts in the biotechnology sector, this endorsement from a reputable analyst could generate increased interest from potential investors keen on the company's progress in medical technology innovation.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 5 analysts, the average target price for VolitionRX Ltd (VNRX, Financial) is $3.13 with a high estimate of $5.00 and a low estimate of $2.00. The average target implies an upside of 461.88% from the current price of $0.56. More detailed estimate data can be found on the VolitionRX Ltd (VNRX) Forecast page.
Based on the consensus recommendation from 5 brokerage firms, VolitionRX Ltd's (VNRX, Financial) average brokerage recommendation is currently 2.2, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for VolitionRX Ltd (VNRX, Financial) in one year is $1.97, suggesting a upside of 253.87% from the current price of $0.5567. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the VolitionRX Ltd (VNRX) Summary page.
